Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Scientists find a new layer of Alzheimer’s hidden in the genome

Scientists found that the 3D organization of DNA is disrupted in several types of brain cells affected by Alzheimer’s disease, altering how important genes are switched on and off. The discovery reveals a previously underexplored layer of the disease that could open new paths for understanding and eventually treating Alzheimer’s.

Penn trial tests ultrafast form of radiation aimed at reducing cancer treatment side effects

The hope, ultimately, is not only to preserve quality of life in patients, but to make radiation therapy more convenient and accessible.

“Instead of 30 to 40 treatments, we can do the treatment in one to five treatments,” said Alexander Lin, a radiation oncologist at Penn and the trial’s lead investigator.

Doctors typically divide a patient’s radiation therapy into dozens of daily treatments over several weeks.

AI-Designed Drug Makes Patients’ Blood Look Biologically Younger, Study Shows

You can’t change the age written on your ID. But what about the age of your body?

A drug designed with the help of artificial intelligence made the blood profiles of people with lung disease look biologically younger, new research reveals.

The result came from six computer models that estimate biological age by examining proteins in the blood. Scientists call them biological aging clocks.

CDK5RAP3Mediated Mitochondrial RQC Alleviates Pathological Cardiac Hypertrophy

BACKGROUND: Recent studies have revealed heterogeneity among ribosomes. Pathological cardiac hypertrophy.

Is characterized by profound alterations in translation. However, how ribosome heterogeneity.

Contributes to this process remains largely unclear. METHODS: We used translating ribosome affinity purification coupled with mass spectrometry.

AI helps microscopes find the most informative nanoscale features in a sample

Researchers at the Department of Energy’s Oak Ridge National Laboratory (ORNL) have developed an artificial intelligence framework that helps researchers use atomic force microscopes to identify important nanoscale features while autonomously targeting the most informative areas of a sample for closer study.

Although atomic force microscopy (AFM) reveals structures as small as molecules, operating the instrument still requires expert judgment about where to scan, how to adjust settings and which features deserve closer study. SimuScan reduces that burden, making AFM faster, more consistent and better suited for high-throughput research.

“Operating an atomic force microscope is a bit like piloting a modern jet,” said Liam Collins, an ORNL senior R&D scientist at the Center for Nanophase Materials Sciences (CNMS). “The hardware has incredible capability, but making full use of it often requires an experienced pilot.” That reliance on specialized expertise slows large-scale studies and makes results more dependent on individual users.

Humanoid Robots And The Cyborg Future Of Human-Machine Integration

China is showcasing the strength of its manufacturing capacity. The United States exhibits remarkable capabilities in artificial intelligence, software development, and advanced computing. Japan possesses profound proficiency in precision robotics and human-centric engineering. Europe, South Korea, Taiwan, and various other technological ecosystems possess essential components of the solution.

The contest has only just begun. The era of humanoids has commenced, yet it remains in its nascent stages. The machinery operating in factories today is rudimentary in comparison to what could develop in the forthcoming decade. As artificial intelligence advances, materials are enhanced to be lighter and more robust, battery technology progresses, sensors gain complexity, and robotic models assimilate knowledge from expansive datasets of the physical realm, humanoid robots may emerge as a pivotal technology of the Acceleration Era.

The primary inquiry has shifted from whether machines will integrate into human surroundings. They have already done so. The question pertains to what we instruct them in, how we safeguard them, how we regulate them, and how we guaranty that their growing physical intelligence ultimately enhances rather than constricts human potential. This will constitute a pivotal technological and policy challenge of the forthcoming decade.

Mayo Clinic researchers find a way to reprogram immune cells and boost chemotherapy response in glioblastoma

ROCHESTER, Minn. — Mayo Clinic researchers have identified a potential new approach to treating glioblastoma that could help the immune system fight the aggressive brain cancer while improving the effectiveness of existing chemotherapy.

The preclinical research, published in Nature Communications, found that inhibiting the enzymatic activity of a protein called MALT1 can reprogram immune cells surrounding glioblastomas, shifting them from a state that helps protect the cancer to one that promotes an antitumor immune response.

Researchers also found that treatment with a MALT1 inhibitor slowed tumor growth in preclinical models and that combining MALT1 with temozolomide, the chemotherapy most commonly used to treat glioblastoma, enhanced temozolomide effectiveness. In one preclinical model, median survival substantially increased when this chemotherapy was combined with MALT1 inhibition in comparison to treatment with temozolomide alone.

Fasting study provides evidence of stem cell regeneration of damaged, old immune system

Research shows fasting can crank up stem cell activity, helping your body rebuild and recharge like never before.

For example, a study from MIT found that after just 24 hours of fasting, mice doubled their intestinal stem cell regeneration.

That’s a small tweak with a big payoff, and it’s got people buzzing about how fasting might unlock a hidden superpower in all of us.

/* */